| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0006-8993(01)03148-1 |
| P698 | PubMed publication ID | 11730700 |
| P50 | author | Peter Gluckman | Q7174263 |
| P2093 | author name string | Sizonenko SV | |
| Williams CE | |||
| Sirimanne ES | |||
| P2860 | cites work | Insulin-like growth factor II is induced during wound repair following hypoxic-ischemic injury in the developing rat brain | Q28564683 |
| Expression of the activin axis and neuronal rescue effects of recombinant activin A following hypoxic-ischemic brain injury in the infant rat. | Q30739816 | ||
| Dose-response curve and optimal dosing regimen of cyclosporin A after traumatic brain injury in rats | Q33924997 | ||
| Mechanisms underlying hypoxia-induced neuronal apoptosis | Q33935219 | ||
| The temporal evolution of hypoglycemic brain damage. I. Light- and electron-microscopic findings in the rat cerebral cortex | Q34199337 | ||
| A role for IGF-1 in the rescue of CNS neurons following hypoxic-ischemic injury | Q34247862 | ||
| Enhanced potency of truncated insulin-like growth factor-I (des(1-3)IGF-I) relative to IGF-I in lit/lit mice | Q34288558 | ||
| Enzymatic conversion of IGF-I to des(1-3)IGF-I in rat serum and tissues: a further potential site of growth hormone regulation of IGF-I action | Q34295738 | ||
| Mechanisms of delayed cell death following hypoxic-ischemic injury in the immature rat: evidence for apoptosis during selective neuronal loss | Q34312208 | ||
| Outcome after ischemia in the developing sheep brain: an electroencephalographic and histological study | Q34352573 | ||
| The protease thrombin is an endogenous mediator of hippocampal neuroprotection against ischemia at low concentrations but causes degeneration at high concentrations | Q35052930 | ||
| Characterization of somatomedins from human fetal brain: identification of a variant form of insulin-like growth factor I | Q35615447 | ||
| Des (1-3) IGF-I potently enhances differentiated cell growth in olfactory bulb organ culture | Q38312984 | ||
| Ability of retinal Müller glial cells to protect neurons against excitotoxicity in vitro depends upon maturation and neuron-glial interactions | Q39062493 | ||
| The role of the insulin-like growth factors in the regulation of brain development | Q39523447 | ||
| Insulin-like growth factor-1 is a potent neuronal rescue agent after hypoxic-ischemic injury in fetal lambs | Q39757754 | ||
| The developing CNS: a scenario for the action of proinsulin, insulin and insulin-like growth factors | Q40527824 | ||
| The biological role of truncated insulin-like growth factor-1 and the tripeptide GPE in the central nervous system | Q40768897 | ||
| A comparison of the biological activity of the recombinant intact and truncated insulin-like growth factor 1 (IGF-1). | Q41256225 | ||
| Identity of neurotrophic molecules released from astroglia by vasoactive intestinal peptide | Q41478941 | ||
| The temporal evolution of hypoglycemic brain damage. II. Light- and electron-microscopic findings in the hippocampal gyrus and subiculum of the rat. | Q41501885 | ||
| Microglia as effector cells in brain damage and repair: focus on prostanoids and nitric oxide | Q41699826 | ||
| Dose- and time-dependence of L-NAME neuroprotection in transient focal cerebral ischaemia in rats | Q42013111 | ||
| Selective neuroprotective effects with insulin-like growth factor-1 in phenotypic striatal neurons following ischemic brain injury in fetal sheep. | Q42483478 | ||
| Early blood-brain barrier changes in the rat following transient complete cerebral ischemia induced by cardiac arrest | Q42499063 | ||
| Vitamin D hormone confers neuroprotection in parallel with downregulation of L-type calcium channel expression in hippocampal neurons. | Q43517443 | ||
| Hypoxia-ischemia in the neonatal rat brain: histopathology after post-treatment with NMDA and non-NMDA receptor antagonists | Q44055116 | ||
| Identification of Gly-Pro-Glu (GPE), the aminoterminal tripeptide of insulin-like growth factor 1 which is truncated in brain, as a novel neuroactive peptide | Q44399796 | ||
| Neuroprotective efficacy of N omega-nitro-L-arginine after focal cerebral ischemia in the mouse and inhibition of cortical nitric oxide synthase | Q48124605 | ||
| Alterations in the neural growth hormone axis following hypoxic-ischemic brain injury | Q48214978 | ||
| The effects of the N-terminal tripeptide of insulin-like growth factor-1, glycine-proline-glutamate in different regions following hypoxic-ischemic brain injury in adult rats. | Q48239072 | ||
| Neuroprotective effects of Gly-Pro-Glu, the N-terminal tripeptide of IGF-1, in the hippocampus in vitro | Q48254313 | ||
| The effects of IGF-1 treatment after hypoxic-ischemic brain injury in adult rats. | Q48259779 | ||
| Isolation and characterization of variant IGF-1 as well as IGF-2 from adult human brain | Q48342472 | ||
| The role of tumour necrosis factor, interleukin 6, interferon-gamma and inducible nitric oxide synthase in the development and pathology of the nervous system | Q48377406 | ||
| Co-ordinated and cellular specific induction of the components of the IGF/IGFBP axis in the rat brain following hypoxic-ischemic injury | Q48399935 | ||
| A non-surgical technique for accurate intracerebral injections in rat | Q48500346 | ||
| Hypoxia-ischemia induces transforming growth factor beta 1 mRNA in the infant rat brain | Q48524216 | ||
| Cerebral interleukin-6 is neuroprotective during permanent focal cerebral ischemia in the rat. | Q48532402 | ||
| The temporal evolution of hypoglycemic brain damage. III. Light and electron microscopic findings in the rat caudoputamen | Q48549496 | ||
| Astrocyte-mediated enhancement of neuronal survival is abolished by glutathione deficiency | Q48559488 | ||
| The biphasic opening of the blood-brain barrier to proteins following temporary middle cerebral artery occlusion | Q48564690 | ||
| The effect of prolonged modification of cerebral temperature on outcome after hypoxic-ischemic brain injury in the infant rat. | Q49020421 | ||
| Truncated IGF-1 exerts trophic effects on fetal brain tissue grafts | Q49035766 | ||
| Peripheral infusion of IGF-I selectively induces neurogenesis in the adult rat hippocampus. | Q49084529 | ||
| Sequential patterns of inhibin subunit gene expression following hypoxic-ischemic injury in the rat brain | Q49129325 | ||
| Intracerebral transportation and cellular localisation of insulin-like growth factor-1 following central administration to rats with hypoxic-ischemic brain injury. | Q52171644 | ||
| Role of insulin-like growth factor binding proteins in limitation of IGF-I degradation into the N-methyl-D-aspartate receptor antagonist GPE: evidence from gonadotrophin-releasing hormone secretion in vitro at two developmental stages. | Q52172974 | ||
| Two models for determining the mechanisms of damage and repair after hypoxic-ischaemic injury in the developing rat brain. | Q52213486 | ||
| The effects of insulin-like growth factor (IGF)-1, IGF-2, and des-IGF-1 on neuronal loss after hypoxic-ischemic brain injury in adult rats: evidence for a role for IGF binding proteins | Q61865404 | ||
| The role of inducible transcription factors in apoptotic nerve cell death | Q70864244 | ||
| Apoptosis in cerebellar granule cells is blocked by high KCl, forskolin, and IGF-1 through distinct mechanisms of action: the involvement of intracellular calcium and RNA synthesis | Q71675839 | ||
| Truncation of IGF-I yields two mitogens for retinal Müller glial cells | Q71798550 | ||
| Neuroprotective activity of HU-211, a novel NMDA antagonist, in global ischemia in gerbils | Q72124391 | ||
| Acute suppression of gonadotropin-releasing hormone secretion by insulin-like growth factor I and subproducts: an age-dependent endocrine effect | Q72259482 | ||
| Immediate-early gene protein expression in neurons undergoing delayed death, but not necrosis, following hypoxic-ischaemic injury to the young rat brain | Q72866466 | ||
| Generation of des-(1-3) insulin-like growth factor-I in serum by an acid protease | Q72876621 | ||
| Effects of somatostatin, octreotide and cortistatin on ischaemic neuronal damage following permanent middle cerebral artery occlusion in the rat | Q73320030 | ||
| Insulin-like growth factor-1-mediated protection from neuronal apoptosis is linked to phosphorylation of the pro-apoptotic protein BAD but not to inhibition of cytochrome c translocation in rat cerebellar neurons | Q73539453 | ||
| Insulin-like growth factor-1 inhibits mature oligodendrocyte apoptosis during primary demyelination | Q74046440 | ||
| Insulin-like growth factor-I prevents apoptosis in neurons after nerve growth factor withdrawal | Q77308520 | ||
| Neuronal death and survival in two models of hypoxic-ischemic brain damage | Q77343222 | ||
| Insulin-like growth factor-I prevents apoptosis in sympathetic neurons exposed to high glucose | Q77395621 | ||
| Neuroprotection by glial metabotropic glutamate receptors is mediated by transforming growth factor-beta | Q77581125 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hypoxia | Q105688 |
| P304 | page(s) | 42-50 | |
| P577 | publication date | 2001-12-01 | |
| P1433 | published in | Brain Research | Q4955782 |
| P1476 | title | Neuroprotective effects of the N-terminal tripeptide of IGF-1, glycine-proline-glutamate, in the immature rat brain after hypoxic-ischemic injury | |
| P478 | volume | 922 |
| Q44760148 | A three amino acid peptide, Gly-Pro-Arg, protects and rescues cell death induced by amyloid beta-peptide |
| Q30760213 | Advances in postnatal neuroimaging: relevance to pathogenesis and treatment of brain injury. |
| Q36427698 | Combination Therapies for Traumatic Brain Injury: Retrospective Considerations |
| Q48962363 | Distinctive neuropathologic alterations in the deep layers of the parietal cortex after moderate ischemic-hypoxic injury in the P3 immature rat brain |
| Q41555531 | Effect of transgenic human insulin-like growth factor-1 on spinal motor neurons following peripheral nerve injury |
| Q48487775 | Electroacupuncture induced spinal plasticity is linked to multiple gene expressions in dorsal root deafferented rats |
| Q38722527 | GPE Promotes the Proliferation and Migration of Mouse Embryonic Neural Stem Cells and Their Progeny In Vitro. |
| Q37479916 | IGF-1 derived small neuropeptides and analogues: a novel strategy for the development of pharmaceuticals for neurological conditions |
| Q37705471 | Inflammatory injury to the neonatal brain - what can we do? |
| Q82623154 | Insulin-Like Growth Factor-1 Regulates Neurite Outgrowth and Neuronal Migration From Organotypic Cultured Dorsal Root Ganglion |
| Q35690505 | Insulin-like growth factor-I peptides act centrally to decrease depression-like behavior of mice treated intraperitoneally with lipopolysaccharide |
| Q37441140 | Lignocaine: neuro-protective or wishful thinking? |
| Q42499967 | Molecular mechanism underlying the cerebral effect of Gly-Pro-Glu tripeptide bound to L-dopa in a Parkinson's animal model |
| Q24651541 | Partial reversal of Rett Syndrome-like symptoms in MeCP2 mutant mice |
| Q88783440 | Perturbation Theory/Machine Learning Model of ChEMBL Data for Dopamine Targets: Docking, Synthesis, and Assay of New l-Prolyl-l-leucyl-glycinamide Peptidomimetics |
| Q38346186 | Potential role of IGF-I in hypoxia tolerance using a rat hypoxic-ischemic model: activation of hypoxia-inducible factor 1alpha |
| Q34063244 | The IGF-derived tripeptide Gly-Pro-Glu is a weak NMDA receptor agonist |
| Q60045414 | The Neuroprotective Effects of Exercise: Maintaining a Healthy Brain Throughout Aging |
| Q38344573 | The role for IGF-1-derived small neuropeptides as a therapeutic target for neurological disorders |
Search more.